In pancreatic cancers, CDK14 has been revealed as a hub gene in the interaction network including the Wnt/β-catenin pathway and phosphoinositide 3-kinase/Akt signaling pathway, and its increased expression is associated with poorer overall patient survival (Yuan et al. 2019). This evidence concerns the gene CDK14 and pancreatic neoplasm.